BENEVOLENTAI revenue breakdown overview

BENEVOLENTAI revenue for the last year amounted to 8.46 M EUR, the most of which — 8.43 M EUR — came from its highest performing source at the moment, Artificial Intelligence-related Technology and Drug Discovery, the year earlier bringing 12.38 M EUR. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought BENEVOLENTAI 8.43 M EUR, and the year before that — 12.38 M EUR.